Outcome | Month | Standard mean difference | 95% confidence interval | P value | Heterogeneity | |
---|---|---|---|---|---|---|
MSC therapy effect | Insulin TDD (U/kg/day) | 3 | − 0.226 | − 0.851/0.398 | 0.477 | 53.1% |
6a | – | – | – | – | ||
12 | − 1.235 | − 3.663/1.193 | 0.319 | 82.4% | ||
HbA1c (%) | 3 | − 1.011 | − 1.919/− 0.103 | 0.029 | 74.2% | |
6a | – | – | – | – | ||
12 | − 1.715 | − 2.386/− 1.045 | 0.000 | 00.0% | ||
c-Peptide (ng/ml) | 3 | 0.243 | − 0.163/0.649 | 0.240 | 00.0% | |
6a | – | – | – | – | ||
12 | 1.234 | 0.612/1.856 | 0.000 | 00.0% | ||
Adjusted HbA1c | 3 | − 1.337 | − 2.296/− 0.377 | 0.006 | 74.8% | |
6a | – | – | – | – | ||
12 | − 3.119 | − 5.132/− 1.087 | 0.003 | 81.2% |